menu toggle
As we continue to evolve our brand to Cencora, you will continue to see visual changes. We will be sunsetting amerisourcebergen.com over time and are actively moving content and information over to cencora.com. Please visit cencora.com if you can't find what you are looking for here.

Webinar Part 2: Leveraging AI within eBV to speed access to therapy

By Shanna Barnes, Myra Reinhardt

Find the right tech mix to help speed access to therapy

Electronic benefit verification (eBV) technology has changed. How can you ensure that you’re always leveraging innovation for your access program? By choosing a consultative patient support partner that focuses on people, process and technology.

Join Lash Group’s Myra Reinhardt, VP, Product Innovation and Analytics, and Shanna Barnes, VP, New Business Development, as they share key considerations for determining the right technology mix for your program.

In Part 2 of this two-part series, you’ll:

  • Get actionable tips for vetting medical and pharmacy BV solutions
  • Learn when and how to move to the next step in activating access solutions for your program
PART 2 Screen Shot 20200501 at 30439 PM

About The Authors

Shanna Barnes
Vice President, Business Development
Lash Group
View Bio
Myra Reinhardt
Vice President, Product Innovation
Biopharma Services
View Bio